VRA Vera Bradley
Vera Bradley earnings company data as of 4:51 AM ET 10/23
- 1 of 1 EPS beats
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q4 | 10 Dec | EPS | — | — | — |
| Rev | — | — | — | ||
| FY2027 Q2 | 15 Sep | EPS | -0.08 | 0.15 | Beat |
| Rev | — | $71.6M | — |
Insider trades
Open-market buys and sales by VRA's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $958K bought by 3 insiders
- None no sales outside a trading plan
- None no planned (10b5-1) sales
-
Ivan Brockman DirectorBuy$50K 10,000 shares at $5.02 +400% to stakeTraded Oct 6 Filed Oct 7
-
Ivan Brockman DirectorBuy$10K 2,500 shares at $4.00 New stakeTraded Sep 25 Filed Sep 29
-
Andrew Meslow DirectorBuy$93K 24,926 shares at $3.73 +4% to stakeTraded Jun 12 Filed Jun 16
-
Ian Bickley CEOBuy$112K 28,901 shares at $3.87 +27% to stakeTraded Jun 12 Filed Jun 16
-
Andrew Meslow DirectorBuy$590K 300,000 shares at $1.97 +100% to stakeTraded Dec 12–15 Filed Dec 15, 2025
-
Ian Bickley DirectorBuy$103K 53,000 shares at $1.94 +6.7% to stakeTraded Dec 12, 2025 Filed Dec 15, 2025
Also filed in the last 12 months, not counted as buying or selling: 14 stock grants and 12 share withholdings for taxes.
SEC filings
Recent issuer filings from EDGAR, 15 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 5.07,9.01 | Filing Doc | |
| DEF 14A | Filing Doc | ||
| 8-K | 5.02 | Filing Doc | |
| 8-K | 1.01,3.03,5.03,7.01,9.01 | Filing Doc | |
| 10-K | Filing Doc | ||
| 8-K | 5.02 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.